Mean platelet volume predicting carotid atherosclerosis in atherothrombotic ischemic stroke

[11] Katdare AD(1993)Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment Stroke 24 35-41

[12] Inamdar AK(1998)Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) Lancet 352 1245-1251

[13] Fisher M(2001)A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials BMJ 323 75-81

[14] Levine PH(1998)Relantionship between intima-media thickness in the common carotid artery and atherosclerosis in the carotid bifurcation Stroke 29 1378-1382

[15] Fullerton AL(1999)The natural course of atherosclerosis I: Incidence and progression Arterioscler Thromb Vasc Biol 19 1484-1490

[16] Butterworth R(1999)The natural course of atherosclerosis II: vascular remodelling Arterioscler Thromb Vasc Biol 19 1491-1498

[17] Bath P(2000)Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study Arterioscler Thromb Vasc Biol 20 529-537

[18] Endler G(2003)Platelet P-selectin facilitates atherosclerotic lesion development Blood 101 2661-2666

[19] Klimesch A(2008)Atherosclerosis risk in communities (ARIC) carotid MRI flow cytometry study of monocyte and platelets markers: intraindividual variability and reliability Clin Chem 54 1363-1371

[20] Sunder-Plassmann H(2008)Role of mean platelet volume in triagging acute coronary syndromes J Thromb Thrombolysis 26 49-54

[11] Katdare AD(1993)Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment Stroke 24 35-41

[12] Inamdar AK(1998)Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) Lancet 352 1245-1251

[13] Fisher M(2001)A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials BMJ 323 75-81

[14] Levine PH(1998)Relantionship between intima-media thickness in the common carotid artery and atherosclerosis in the carotid bifurcation Stroke 29 1378-1382

[15] Fullerton AL(1999)The natural course of atherosclerosis I: Incidence and progression Arterioscler Thromb Vasc Biol 19 1484-1490

[16] Butterworth R(1999)The natural course of atherosclerosis II: vascular remodelling Arterioscler Thromb Vasc Biol 19 1491-1498

[17] Bath P(2000)Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study Arterioscler Thromb Vasc Biol 20 529-537

[18] Endler G(2003)Platelet P-selectin facilitates atherosclerotic lesion development Blood 101 2661-2666

[19] Klimesch A(2008)Atherosclerosis risk in communities (ARIC) carotid MRI flow cytometry study of monocyte and platelets markers: intraindividual variability and reliability Clin Chem 54 1363-1371

[20] Sunder-Plassmann H(2008)Role of mean platelet volume in triagging acute coronary syndromes J Thromb Thrombolysis 26 49-54